PRVA
Undervalued by 38.5% based on the discounted cash flow analysis.
Market cap | $2.17 Billion |
---|---|
Enterprise Value | $1.78 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.19 |
Beta | 0.0 |
Outstanding Shares | 118,655,540 |
Avg 30 Day Volume | 837,295 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 93.88 |
---|---|
PEG | -111.72 |
Price to Sales | 1.42 |
Price to Book Ratio | 4.6 |
Enterprise Value to Revenue | 1.07 |
Enterprise Value to EBIT | 86.06 |
Enterprise Value to Net Income | 77 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for del...